Magnetic Resonance Clinical Trials

89 recruitingLast updated: June 18, 2026

There are 89 actively recruiting magnetic resonance clinical trials across 18 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1. Top locations include Beijing, China, Zurich, Canton of Zurich, Switzerland, Amiens, France. Updated daily from ClinicalTrials.gov.


Magnetic Resonance Trials at a Glance

89 actively recruiting trials for magnetic resonance are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 41 trials, with the heaviest enrollment activity in Beijing, Zurich, and Amiens. Lead sponsors running magnetic resonance studies include Centre Hospitalier Universitaire, Amiens, Anhui Medical University, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse magnetic resonance trials by phase

Treatments under study

About Magnetic Resonance Clinical Trials

Looking for clinical trials for Magnetic Resonance? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Magnetic Resonance trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Magnetic Resonance clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 89 trials

Recruiting

Study of New Magnetic Resonance Imaging Methods of the Brain

HealthyHealthy VolunteerAdult+3 more
National Institute of Neurological Disorders and Stroke (NINDS)1,100 enrolled1 locationNCT00004577
Recruiting
Not Applicable

The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

Cardiac Magnetic Resonance ImagingIschemic Heart Disease (IHD)Myocardial Blood Flow
Brigham and Women's Hospital1,000 enrolled12 locationsNCT06854458
Recruiting
Not Applicable

Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy

Autobiographical MemoryDepression - Major Depressive DisorderTreatment Outcome+6 more
Anders Jørgensen145 enrolled1 locationNCT07619092
Recruiting
Not Applicable

Effects of Ketogenic Diet on Alcohol Intoxication

Magnetic Resonance ImagingAlcohol DrinkingAlcohol Use Disorder+2 more
University of Pennsylvania20 enrolled1 locationNCT07602270
Recruiting
Not Applicable

Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

Magnetic Resonance ImagingEcological Momentary AssessmentAttentional Bias+4 more
University of Arkansas255 enrolled1 locationNCT05336188
Recruiting
Not Applicable

MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis

Multiple SclerosisMagnetic Resonance Spectroscopy
Poitiers University Hospital50 enrolled1 locationNCT05491031
Recruiting
Not Applicable

FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))

Cardiac Magnetic Resonance ImagingArrhythmogenic Right Ventricular CardiomyopathyFAPI PET
Istanbul University - Cerrahpasa15 enrolled1 locationNCT07563660
Recruiting
Phase 1Phase 2

COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER

Colorectal, CancerStenosisFibrosis, Liver+4 more
Massachusetts General Hospital80 enrolled1 locationNCT05692024
Recruiting
Not Applicable

Non-Invasive Monitoring Of Metabolite Levels Using Novel And Adapted MR Spectroscopy Techniques

Magnetic Resonance Spectroscopy
Insel Gruppe AG, University Hospital Bern100 enrolled1 locationNCT05165537
Recruiting
Phase 2

Ketamine Alcohol (in Treatment-Resistant Depression)

Magnetic Resonance ImagingAlcoholismMajor Depression
Mark Niciu60 enrolled1 locationNCT02122562
Recruiting
Not Applicable

ETASCAN Project: ETAS Project 2

MRISleepCognition+3 more
University of Reading60 enrolled1 locationNCT07550140
Recruiting
Phase 3

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions

For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions
Shanghai Shengdi Pharmaceutical Co., Ltd250 enrolled2 locationsNCT07275814
Recruiting

Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy

Heart FailurePrognosisRisk Assessment+4 more
Shandong Provincial Hospital2,000 enrolled1 locationNCT07527715
Recruiting
Phase 3

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions

For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)
Shanghai Shengdi Pharmaceutical Co., Ltd306 enrolled2 locationsNCT07275723
Recruiting
Phase 2Phase 3

Effect of Nutritional Ketosis on Alcohol Metabolism

Magnetic Resonance ImagingAlcohol DrinkingKetogenic Dieting+2 more
University of Pennsylvania20 enrolled1 locationNCT06065657
Recruiting
Not Applicable

Quantitative T1rho Magnetic Resonance Imaging in Healthy Subjects

Magnetic Resonance Imaging
Chinese University of Hong Kong30 enrolled1 locationNCT04993196
Recruiting

Heart Transplantation - Renewal

Magnetic Resonance ImagingTransplant, Heart
Northwestern University247 enrolled2 locationsNCT05521399
Recruiting

Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis

ClaudicationDisability PhysicalMagnetic Resonance+2 more
Marmara University100 enrolled1 locationNCT07233798
Recruiting
Not Applicable

Test and Optimization of New Specific MRI Sequences on an Imager Dedicated to Research

Magnetic Resonance Imaging Sequences
University Hospital, Bordeaux200 enrolled1 locationNCT03674645
Recruiting

MR Guidance for Liver and Pancreas

Magnetic Resonance Imaging
University Health Network, Toronto30 enrolled1 locationNCT03582189